InvestorsHub Logo
Followers 21
Posts 1954
Boards Moderated 0
Alias Born 11/14/2018

Re: None

Saturday, 12/23/2023 5:42:06 PM

Saturday, December 23, 2023 5:42:06 PM

Post# of 198726
Here is a good read that the good doctor predicted revenue ect from a year and half ago Full read below but here is just one out take and stage three trials cleared for ITV-1 hum.

"Have you considered where your valuation may end up six months to two years from now?", asked Jolly. "The market cap is not reflecting the full potential of Enzolytics," said Dr. Chandra, noting the significant market for each of the Company's products. "The next product that we have is ITV-1, which is an HIV therapeutic and has actually cleared Phase III clinical trials and is preparing for introduction into two markets," he explained. "The African market is a significant market because 65% of about 34 to 37 million HIV infected individuals live in Africa."

"We will also be introducing this product into Europe, and are currently awaiting certification under the European Medical Agency," shared Dr. Chandra.

https://www.newsfilecorp.com/release/124101/Enzolytics-Inc.-Discusses-the-Significance-and-Revenue-Potential-of-Its-Therapeutic-Platforms-with-The-Stock-Day-Podcast